✦ LIBER ✦

Comparison of daily interferon ALFACON-1 with standard regimens of thrice weekly interferon ALFACON-1 in patients with chronic hepatitis C — interim results from an ongoing international trial

✍ Scribed by S. Zeuzem; M. Manns; V. Rustgi; S. Aurora; C. Smith; M. Shiffman; R. Reddy; R. Reindollar; D. Slaker; R. Rai

Book ID: 119527480
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 132 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)81525-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter randomized trial of 15mcg al

Multicenter randomized trial of 15mcg alfacon-1 administered daily vs.thrice weekly in patients with chronic hepatitis C who did not respond to interferon therapy: Initial response and tolerability

✍ Fong, Tse-Ling; Pauly, Mary Pat; Zacks, Steven; Kahn, Jeffrey; Sze, Gloria; Schu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Effect of daily interferon alfacon-1 on

Effect of daily interferon alfacon-1 on response rates of previously treated non-responder chronic hepatitis C patients, with emphasis on rates in african american and genotype 1 populations-a preliminary report

✍ McCone, Jonathan; Baldwin, Julie; McCone, Bonnie 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Interferon-alfacon-1 shows efficacy in p

Interferon-alfacon-1 shows efficacy in patients with chronic hepatitis C who have not responded to, or relapsed after, prior therapy with IFN-α-2b plus ribavirin

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Clinical trial: comparison of weekly onc

Clinical trial: comparison of weekly once versus twice half-dose weekly administration of pegylated interferon alpha 2b in combination with ribavirin for the treatment of HCV-1 positive patients with chronic hepatitis C

✍ G. SEBASTIANI; A. FERRARI; S. BOCCATO; R. PISTIS; A. ALBERTI 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

101 SVR4 AND SVR12 WITH AN INTERFERON-FR

101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SOUND-C2

✍ S. Zeuzem; V. Soriano; T. Asselah; J.-P. Bronowicki; A. Lohse; B. Müllhaupt; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l